Xh. Liu et Dp. Rose, SUPPRESSION OF TYPE-IV COLLAGENASE IN MDA-MB-435 HUMAN BREAST-CANCER CELLS BY EICOSAPENTAENOIC ACID IN-VITRO AND IN-VIVO, Cancer letters, 92(1), 1995, pp. 21-26
Dietary supplementation with 4% eicosapentaenoic acid (EPA), a long-ch
ain polyunsaturated fatty acid, suppressed the development of lung met
astases in nude mice from MDA-MB-435 human breast cancer cell mammary
fat pad solid tumors. Zymography of primary tumor homogenates showed t
hat this inhibition of metastasis was associated with reduced levels o
f 92-kDa type IV collagenase gelatinolytic activity; this isoform has
been previously associated with the metastatic phenotype. The 72-kDa i
soform, which was also present, may have arisen from the cancer cells,
or tumor-associated host cells. In vitro, the incorporation of EPA, 0
.25-1.0 mu g/ml into the medium caused a concentration-related suppres
sion of cultured MDA-MB-435 cell 92-kDa type IV collagenase mRNA expre
ssion.